HIV/AIDS influences blood and blood product use at Groote Schuur Hospital, Cape Town

South African Medical Journal

Volumn 101, Issue 7, 2011, Pages 463-466

  Ntusi, Ntobeko B ^a   Sonderup, Mark W ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIRETROVIRUS AGENT; BLOOD DERIVATIVE; FRESH FROZEN PLASMA; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOPENIA; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; SOUTH AFRICA; STRUCTURED QUESTIONNAIRE; BLOOD COMPONENT THERAPY; GENERAL HOSPITAL; UTILIZATION REVIEW;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIGENS, CD4; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; FEMALE; HIV INFECTIONS; HOSPITALS, GENERAL; HUMANS; MALE; SOUTH AFRICA;

EID: 79960976521     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zon LI, Arkin C, Groopman JE. Haematologic manifestations of the human immunodefciency virus (HIV). Br J Haematol 1987;66:251-256.
2. Moore RD. Anemia and human immunodefciency virus disease in the era of highly active antiretroviral therapy. Semin Hematol 2000;7:18-23.
3. Varney SJ, Guest J.F. Te annual cost of blood transfusions in the UK. Transfusion Med 2003;13:205-218.
4. Moyle G. Anaemia in persons with HIV: prognostic marker and contributor to morbidity. AIDS Rev 2002;14:13-20.
5. O'Brien ME, Kupka R, Msamanga GI, et al. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defc Syndr 2005;40:219-225.
6. Sullivan PS, Hanson DL, Chu SY, et al. Epidemiology of anemia in human immunodefciency virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998;91:301-308.
7. Groopman J. Impact of transfusion on viral load in human immunodefciency virus infection. Semin Hematol 1997;34(suppl 2):27-33.
8. Costantini A, Giuliodoro S, Butini L, et al. HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy. Current HIV Res 2010;8:336-339.
9. Badri M, Maartens G, Mandalia S, et al. Cost-efectiveness of highly active antiretroviral therapy in South Africa. PLoS Med 2006;3:e4.
10. Wood E, Braitstein P, Montaner J, et al. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet 2000;355:2095-2100.
11. Richman DD, Fischl MA, Grieco MH, et al. Te toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987;317:192-197.